As previously confirmed, insulin not only influences malignant cancer cells promotion directly via some signaling pathways, but also induces carcinogenic effects indirectly through production of some inflammatory cytokines such as interleukin-6 (IL-6) and C-reactive protein (CRP) [45, 46]. The gene discussed is CRP; the disease is cancer.